XML 31 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Total Edwards Lifesciences Corporation Stockholders' Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Common stock, beginning balance (in shares) at Dec. 31, 2022     646.3          
Beginning balance at Dec. 31, 2022 $ 5,806.7 $ 5,806.7 $ 646.3 $ (4,144.0) $ 1,969.3 $ 7,590.0 $ (254.9) $ 0.0
Treasury stock, beginning balance (in shares) at Dec. 31, 2022       38.0        
Increase (Decrease) in Stockholders' Equity                
Net income 340.5 340.5       340.5    
Other comprehensive loss, net of tax (0.5) (0.5)         (0.5)  
Common stock issued under stock plans (in shares)     0.8          
Common stock issued under stock plans 41.9 41.9 $ 0.8   41.1      
Stock-based compensation expense 38.9 38.9     38.9      
Purchases of treasury stock (in shares)       3.1        
Purchases of treasury stock (249.5) (249.5)   $ (249.5)        
Changes to noncontrolling interest 84.0             84.0
Common stock, ending balance (in shares) at Mar. 31, 2023     647.1          
Ending balance at Mar. 31, 2023 $ 6,062.0 5,978.0 $ 647.1 $ (4,393.5) 2,049.3 7,930.5 (255.4) 84.0
Treasury stock, ending balance (in shares) at Mar. 31, 2023       41.1        
Common stock, beginning balance (in shares) at Dec. 31, 2023 601.1   650.5          
Beginning balance at Dec. 31, 2023 $ 6,719.4 6,650.0 $ 650.5 $ (5,024.5) 2,274.4 8,992.4 (242.8) 69.4
Treasury stock, beginning balance (in shares) at Dec. 31, 2023 49.4     49.4        
Increase (Decrease) in Stockholders' Equity                
Net income $ 351.0 351.9       351.9   (0.9)
Other comprehensive loss, net of tax 9.5 9.5         9.5  
Common stock issued under stock plans (in shares)     1.3          
Common stock issued under stock plans 62.1 62.1 $ 1.3   60.8      
Stock-based compensation expense 44.6 44.6     44.6      
Purchases of treasury stock $ (0.2) (0.2)   $ (0.2)        
Common stock, ending balance (in shares) at Mar. 31, 2024 602.4   651.8          
Ending balance at Mar. 31, 2024 $ 7,186.4 $ 7,117.9 $ 651.8 $ (5,024.7) $ 2,379.8 $ 9,344.3 $ (233.3) $ 68.5
Treasury stock, ending balance (in shares) at Mar. 31, 2024 49.4     49.4